To examine the role of Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII) in cell differentiation and neuronal functions, stable transformants of PC12 cells were established that expressed levels of the ␣-subunit of CaMKII (␣CaMKII) equivalent to mammalian neurons. The expression of the transfected ␣CaMKII gene or the endogenous ␤CaMKII gene was monitored by RNase protection assays, and ␣CaMKII protein expression was determined by Western blots. Several PC12-derived clones expressed amounts of ␣CaMKII mRNA and ␣CaMKII protein similar to that of hippocampal tissues and several orders of magnitude greater than untransfected PC12 cells. CaMKII catalytic activity was four times higher in extracts from ␣CaMKII-overexpressing compared with untransfected PC12 cells. All clones overexpressing ␣CaMKII displayed altered cellular growth and adhesion properties including increased cell-to-substrate adhesion, decreased cell-to-cell adhesion, enhanced contact inhibition, and prolonged survival at confluency. Furthermore, the ␣CaMKII activity in overexpressing PC12 cells inhibited neurite elongation during NGF-induced differentiation. Inhibition of CaMKII activity in vivo with KN-62 caused the morphological phenotypes of ␣CaMKII-overexpressing cells to partially revert to that of untransfected PC12 cells. These results show that ␣CaMKII catalytic activity affects growth, morphology, and NGF-induced differentiation of PC12 cells.
To examine the role of Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII) in cell differentiation and neuronal functions, stable transformants of PC12 cells were established that expressed levels of the ␣-subunit of CaMKII (␣CaMKII) equivalent to mammalian neurons. The expression of the transfected ␣CaMKII gene or the endogenous ␤CaMKII gene was monitored by RNase protection assays, and ␣CaMKII protein expression was determined by Western blots. Several PC12-derived clones expressed amounts of ␣CaMKII mRNA and ␣CaMKII protein similar to that of hippocampal tissues and several orders of magnitude greater than untransfected PC12 cells. CaMKII catalytic activity was four times higher in extracts from ␣CaMKII-overexpressing compared with untransfected PC12 cells. All clones overexpressing ␣CaMKII displayed altered cellular growth and adhesion properties including increased cell-to-substrate adhesion, decreased cell-to-cell adhesion, enhanced contact inhibition, and prolonged survival at confluency. Furthermore, the ␣CaMKII activity in overexpressing PC12 cells inhibited neurite elongation during NGF-induced differentiation. Inhibition of CaMKII activity in vivo with KN-62 caused the morphological phenotypes of ␣CaMKII-overexpressing cells to partially revert to that of untransfected PC12 cells. These results show that ␣CaMKII catalytic activity affects growth, morphology, and NGF-induced differentiation of PC12 cells. Calcium /calmodulin-dependent protein kinase II (CaMKII) is one of the most abundant neuronal protein kinases (Kelly, 1991) . The activity of CaMKII was first identified in neuronal membrane fractions (Schulman and Greengard, 1978) , and the ␣-subunit of CaMKII was later identified as the major postsynaptic density protein (mPSDp) (Kennedy et al., 1983; Rostas et al., 1983; Kelly et al., 1984; Sahyoun et al., 1985) . The mPSDp displays characteristics of a structural protein, such as insolubility in chaotropic agents (Kelly and Cotman, 1976a; Feit et al., 1977) , and a propensity to form disulfide bonds with itself and other synaptic proteins (Kelly and Cotman, 1976b) . CaMKII is distinct from all known cytoskeletal /structural proteins (Kelly and Cotman, 1976a) and represents 30 -40% of total proteins in PSDs, suggesting that ␣CaMKII could function as a structural /cytoskeletal protein at synapses (Kelly, 1991; Schulman and Hanson, 1993) . Among the proteins present in PSDs, tubulin, actin, and fodrin are found in stoichiometric amounts, suggesting that ␣CaMKII could form complexes with these cytoskeletal proteins (Carlin et al., 1983; Sahyoun et al., 1985 Sahyoun et al., , 1986 . Purified cytoplasmic CaMKII also appears to interact under in vitro conditions with polymers of purified actin (Ohta et al., 1986) . However, the mechanisms regulating the accumulation of ␣CaMKII at synapses, as well as its function in the developing brain, are largely unknown (Kelly, 1991) .
CaMKII phosphorylates a broad range of substrates and is expected to have pleiotropic regulatory actions in cellular differentiation and mature neuronal functions. For example, CaMKII in the neuronal nuclear matrix and PSDs are structurally related and phosphorylate a broad range of substrates in these cellular compartments (Sahyoun et al., 1984a,b) . The activity of CaMKII also appears to be involved in nuclear membrane breakdown (Baitinger et al., 1990) . Expression of a truncated, constitutively active form of CaMKII in mammalian cells leads to arrest of the cell cycle in G2 (Planas- Silva and Means, 1992) . In addition, the activity of CaMKII in postsynaptic hippocampal neurons is necessary for the induction of long-term potentiation Wang and Kelly, 1995) , a cellular model of learning in mammals.
Expression of high levels of ␣CaMKII in a cell model is important to understand its potential role as an enzyme and /or a structural protein (Sahyoun et al., 1985 (Sahyoun et al., , 1986 . The studies herein have examined the hypothesis that ␣CaMKII overexpression alters the general cell growth, differentiation, and morphology of neurons. Our goal was to develop a cellular model that displays high levels of CaMKII expression characteristic of many CNS neurons. The PC12 cell model described herein allowed us to examine a number of cellular changes associated with ␣CaMKII expression and NGF-induced cell differentiation and determine which cellular properties require ␣CaMKII catalytic activity versus its potential function as a cytoskeletal /structural protein (T. Massé and P. Kelly, unpublished observations). A role for CaMKII in cellular morphology has been reported in neuroblas-toma NB2a and NG-108 cells (Goshima et al., 1993) or PC12 cells (Tashima et al., 1996) using experimental strategies somewhat like ours. We found that overexpression of ␣CaMKII in PC12 cells greatly enhances cell survival in confluent cultures, increases cell-to-substrate adhesion, and greatly inhibits neurite outgrowth during NGF-induced cellular differentiation. A preliminary account of these results appeared elsewhere (Massé et al., 1993) .
MATERIALS AND METHODS
Cell culture, transfection, and clonal selection. PC12 cells were grown in DMEM (5-10% CO 2) supplemented with 10% horse serum and 5% fetal calf serum (FCS). Differentiation was induced by incubating cells with 50 nM NGF (generously provided by William Mobley, UCSF) in DMEM ϩ 1% FCS.
The cDNA encoding ␣CaMKII (rat brain) was subcloned into the eukaryote expression vector pRc/cytomegalovirus (CMV, Invitrogen) containing the early CMV promoter and genes for neomycin and ampicillin resistance (pCMV-␣CaMKII). PC12 cells were plated on poly-Lornithine-coated tissue culture plates and transfected 24 hr later with plasmids linearized with ScaI (cutting in the ampicillin gene, increasing the likelihood of integrating the full-length plasmid with intact ␣CaMKII and neomycin resistance genes). Transfections were done by the Ca 2ϩ phosphate method (Graham and van der Eb, 1973) ; precipitates were left on cells for 16 hr, washed with DMEM, and incubated in complete medium for 24 hr before adding the neomycin analog G418. Stable transfectants were selected over 2 weeks in medium containing G418 (0.5-3.0 mg/ml). Clones were isolated and maintained under G418 selection for 2 additional weeks; clones overexpressing ␣CaMKII (␣PC12) were identified by immunofluorescence.
RNase protection. [ 32 P]cRNAs were prepared from pCMV-␣CaMKII or pCMV-␤-CaMKII (␤-CaMKII cDNA was a gift from Dr. Rachael Neve) linearized with ClaI or HinfI, respectively. SP6 RNA polymerase (Melton et al., 1984) was used to generate 32 P-labeled probes, which were hybridized overnight at 55ЊC to total cellular RNA prepared from rat hippocampus, untransfected PC12 cells, or ␣CaMKII-overexpressing PC12 cells. Single-strand cRNAs were digested at room temperature for 1 hr with 40 g/ml RNase A ϩ 3000 U/ml RNase T1; [ 32 P]cRNA fragments were sized on polyacrylamide/urea sequencing gels.
In vitro phosphorylation. Cells were harvested by scraping in PBS, pelleted (1000 ϫ g/10 min) at 4ЊC, resuspended in 150 l of ice-cold homogenization buffer containing (in mM): 10 Tris-HCl pH 7.5, 1 EGTA, 1 EDTA, 0.5 dithiothreitol (DTT), 0.1 phenylmethylsulfonyl fluoride, and 5 g/ml leupeptin and 20 g/ml soybean trypsin-inhibitor, and sonicated for 5 sec. Protein concentrations were determined by the micro-BCA method (Pierce). Phosphorylation reactions were initiated by adding 5 or 10 g of cellular extract protein (in 10 l) to 40 l of a solution, such that the following final concentrations were obtained (in mM): 25 HEPES, pH 7.4, 10 MgCl 2 , 0.5 DTT, 2 CaCl 2 , 1.5 M CaM, and 50 M ATP and 3.5 Ci 32 P-␥-ATP (3000 Ci/mmole). Certain reactions contained 20 M autocamtide-3, a peptide substrate for CaMKII (Hanson and Schulman, 1992) . To determine Ca 2ϩ -independent CaMKII activity in cell extracts, Ca 2ϩ /CaM was replaced with 0.5 mM EGTA or 0.5 mM EGTA ϩ 50 M of a pseudosubstrate peptide inhibitor of CaMKII [Ala 286 (281-302)] (Hanson and Schulman, 1992) . Phosphorylation reactions (31ЊC for 45 or 60 sec) were linear with respect to time and protein concentration (5-10 g) and were terminated by the addition of 4ϫ SDS sample buffer and heated at 85ЊC for 5 min or spotted on phosphocellulose filters, as described elsewhere .
RESULTS ␣CaMKII overexpression in PC12 cells
In initial experiments, NB2a and NG-108 cells proved unsuitable as cellular models for the overexpression of ␣CaMKII. First, we were unable to select clones expressing high levels of ␣CaMKII (e.g., similar to rat hippocampal neurons). Second, we found that the expression of ␣CaMKII under the regulation of several promoters (e.g., CMV, RSV, and SV-40) was inhibited when cellular differentiation of these cell lines was induced by 8-bromo-cAMP or retinoic acid (data not shown). In contrast, stable PC12 cell transformants were routinely obtained that expressed high levels of ␣CaMKII that approximated its expression in hippocampal neurons. In addition, short-term growth (ϳ4 hr) of ␣CaMKII-overexpressing PC12 cells in NGF produced a transient increase in ␣mRNA levels (data not shown), which was expected because the CMV promoter contains a serum response element that can be stimulated by NGF.
Independent clones (ϳ100) overexpressing ␣CaMKII were selected and studied. The level of ␣CaMKII expression in untransfected versus transformed PC12 (␣PC12) cells was determined using RNase protection assays. Total RNA from rat hippocampus and ␣CaMKII-overexpressing cells showed protected fragments of the expected size for ␣CaMKII mRNA ( Fig. 1 A, a) . The levels of ␣CaMKII mRNA in several ␣CaMKII-overexpressing cell lines were comparable with levels in rat hippocampus. In contrast, very low ␣-mRNA signals Figure 1 . Analysis of ␣CaMKII mRNA and protein expression in PC12 cells and hippocampus. A, RNase protection analysis of ␣CaMKII (a) and ␤CaMKII (b) mRNAs in normal and ␣CaMKII-overexpressing PC12 cells or hippocampal tissue from adult rat brain. Total cellular RNA from two different PC12 cultures, two independent clones overexpressing ␣CaMKII, or hippocampi were analyzed. Equivalent amounts of RNA were hybridized with subunit-specific cRNA probes and digested with RNase A ϩ T1 (see Materials and Methods). Autoradiograms show cRNA fragments protected by mRNAs from ␣CaMKII-overexpressing cells (lanes 1, 2) were detected after RNase protections using RNA prepared from untransfected PC12 cells. Densitometry of autoradiograms showed that untransfected PC12 cells contained ϳ100-to 250-fold less ␣-mRNA than ␣PC12 cells. A probe specific for ␤-CaMKII mRNA demonstrated that its concentration was similar in untransfected and ␣PC12 cells, but ϳ2 times lower than rat hippocampal RNA. Western blot analysis showed high levels of ␣CaMKII in most G418 resistant clones after transfection, whereas ␣CaMKII was undetectable in untransfected PC12 cells (Fig. 1 B) . Many PC12 clones expressed levels of ␣CaMKII comparable with rat hippocampus (i.e., ϳ2% of total protein) (Erondu and Kennedy, 1985) . Although most of the results presented herein were with the two ␣PC12 clones shown in Figure 1 , we observed the same overall phenotype for numerous clones that expressed as little as 25% as much ␣CaMKII.
The Ca 2ϩ /CaM-stimulated CaMKII activity in ␣PC12 cell extracts was ϳ50% greater than the activity measured in hippocampal extracts, as determined by the in vitro phosphorylation of autocamtide-3 (see Materials and Methods). In addition, ␣PC12 cells contained 4.1 Ϯ 0.6 (n ϭ 6) times higher Ca 2ϩ /CaM-stimulated CaMKII activity compared with untransfected cells. The Ca 2ϩ -independent CaMKII activity in cell extracts was determined in assays containing EGTA, with or without a pseudosubstrate inhibitor of CaMKII ]. Although ␣PC12 cells contained significantly more Ca 2ϩ / CaM-dependent CaMKII activity compared with untransfected PC12 cells, the percentage of total CaMKII activity that was Ca 2ϩ -independent in ␣PC12 cells (9.8 Ϯ 0.4%, n ϭ 10) was very similar to the Ca 2ϩ -independent activity in extracts from untransfected cells (9.3 Ϯ 1.1%). We also examined the distribution of CaMKII activity in crude soluble (S1) and particulate (P1) fractions prepared from ␣PC12 and untransfected PC12 cell homogenates (Table 1) . These results indicated that ␣PC12 cells contained ϳ3.8 Ϯ 1.1 (n ϭ 4) times more Ca 2ϩ /CaMstimulated CaMKII activity compared with untransfected cells. The percentage of total CaMKII activity that was Ca 2ϩ -independent in S1 and P1 fractions from ␣PC12 cells (5.1 Ϯ 1.7%, n ϭ 4) was 50% lower compared with untransfected cells (9.3 Ϯ 0.6%, n ϭ 4). These results indicate that although the percentage of Ca 2ϩ -independent CaMKII activity in ␣PC12 cells is slightly lower than untransfected PC12, the absolute amount of Ca 2ϩ -independent activity is higher (three-to fourfold) in ␣PC12 cells.
The in vitro phosphorylation of endogenous proteins in cell extracts was analyzed by SDS-PAGE and autoradiography. Scanning densitometry of autoradiograms showed that the Ca 2ϩ /CaMdependent phosphorylation of several proteins was four-to sixfold greater in ␣PC12 cell extracts compared with untransfected PC12 cells (data not shown). These results confirm that ␣CaMKII-overexpressing PC12 clones contain similar levels of functional CaMKII activity compared with hippocampal tissue, which makes them a suitable model to study the role of CaMKII in neuronal functions.
␣CaMKII overexpression alters cell growth and adhesion properties A majority of clones overexpressing ␣CaMKII displayed very similar growth properties. Within 30 -60 min after plating, ␣PC12 cells attached and spread on substratum; all were flat and phasecontrasted within 24 hr. Under similar conditions, untransfected PC12 cells displayed small, round, and phase-bright morphologies, which by 24 hr, remained the predominant phenotype (data not shown). Over the course of 3-5 d in culture, untransfected PC12 cells flattened and grew as tight aggregates, whereas ␣PC12 cells remained flat and separated from one another, with distinct cell borders (Fig. 2) . In contrast, clones selected for overexpression of ␤-galactosidase (under control of the CMV promoter) displayed morphological properties (Ϯ NGF) that were similar to untransfected PC12 cells (data not shown).
When untransfected PC12 cells were plated on plastic bacteriological Petri dishes, Ͻ10% of the cells attached within 24 hr, and most cells formed suspension aggregates (data not shown). In contrast, ϳ50% of ␣PC12 cells attached to bacteriological plastic within 60 min of plating, and all attached within 24 hr (data not shown). The morphology and growth cones of G418-resistant ␣PC12 clones expressing very low or undetectable levels of ␣CaMKII were similar to that of untransfected PC12 cells. These differences in cell morphology indicated that ␣CaMKII overexpression results in increased cell-to-substrate adhesion and decreased cell-to-cell contact.
During the first 3 d after trypsinization and replating, the initial replication rate of ␣PC12 cells was ϳ50% slower than untransfected PC12 cells (Fig. 3) . However, during exponential growth (3-6 d after replating), both ␣PC12 and untransfected PC12 cells displayed similar growth rates. ␣PC12 cells stopped dividing at lower cell densities. The slower initial replication rate and the PC12 cell and tissue homogenates (H) were prepared in homogenization buffer (see Materials and Methods) using a Dounce homogenizer; homogenates were centrifuged 10,000 ϫ g (10 min /4ЊC) to prepare crude particulate (P1) and soluble (S1) fractions. Values (average of duplicates) are from a representative experiment; phosphorylation reactions used 5 g of extract protein (0.1 g for CaMKII); CaMKII was purified as described elsewhere . A background value for each phosphorylation condition was obtained with reactions to which extract protein was not added (background was subtracted from each experimental value).
inhibition of replication at lower cell density both suggest that contact inhibition is enhanced in ␣PC12 cells. ␣PC12 cells displayed a high capacity to survive after reaching confluency compared with untransfected cells (Fig. 3) . Untransfected PC12 cells underwent significant cell death 2-3 d after reaching confluency, even though half of the culture medium was replaced with fresh medium every 2 d. In contrast, ␣PC12 cells showed little cell death for Ͼ7-10 d after reaching confluency; in several experiments, confluent cultures of ␣PC12 cells displayed no apparent cell death for 3-4 weeks (data not shown).
␣CaMKII overexpression alters cellular response to NGF Because PC12 cells overexpressing ␣CaMKII displayed distinct growth properties under standard culture conditions, we examined their behavior during NGF-induced cell differentiation. All clones overexpressing ␣CaMKII displayed very similar morphologies during NGF-induced cell differentiation. Within 1-2 hr after adding NGF (50 nM) and decreasing serum from 15 to 1%, ␣PC12 cells flattened and formed numerous growth cone-like structures, which did not extend from the perimeter of the cell body (Fig. 4) . Even after 2-3 d in NGF, ␣PC12 cells still displayed large growth cones with little or no neurite extension (Figs. 4 A, 5 ). Untransfected PC12 cells, or G418 selected clones that did not overexpress ␣CaMKII, rapidly extended many long neurites in NGF (Fig. 4 B) . At least 4 -5 d in NGF was required for a significant number of ␣PC12 cells to extend neurites longer than 1 cell body diameter (see below). Untransfected PC12 cells grown in NGF for 4 d displayed long and slender neurites that appeared to contact the substrate only once or twice throughout their length (Fig. 4 B) . This apparent weak substrate adhesion of untransfected PC12 neurites was supported by their fragility during media changes or histochemical processing. In contrast, the very short neurites of ␣PC12 cells, when present, appeared flat, wide at their base, and more strongly adherent to the substratum compared with neurites of untransfected cells (see Fig. 4 A) . Thus, the overexpression of ␣CaMKII appeared to inhibit neurite elongation, promote growth cone flattening, and increase the adhesion of cells and neurites to substrate.
To determine whether these alterations in cell morphology and inhibition of neurite extension required ␣CaMKII activity, ␣PC12 cells were cultured in KN-62, an inhibitor of CaMKII (IC 50 of ϳ1 M when assayed using purified CaMKII) (see Tokumitsu et al., 1990) . Cell morphologies were analyzed by phase-contrast microscopy after differentiation in NGF ϩ or Ϫ KN-62 (1-10 M). Neurite extension was assessed by counting cells presenting short neurites (length Յ 1 body diameter) and cells with long neurites (length Ն 1 cell body diameter). After 2 d in NGF, 72% of untransfected PC12 cells displayed long neurites and 22% short neurites (Table 1) . Time-lapse microscopy of growth cone dynamics. Phase-contrast micrographs of ␣CaMKII-overexpressing PC12 cells after culture in NGF for 2 d. Sequential micrographs of the same cells every 3 hr showed that growth cones are not stable during a 6 hr period (white arrowheads); after growth cone retraction /collapse, they reappear at the same location on the cell surface (black arrowheads). Scale bar, 50 m.
for 2 d displayed highly differentiated morphologies, with 33% displaying long neurites and 43% short neurites (Table 1, Fig. 4C ). Because this KN-62 concentration is 10 times higher than its in vitro IC 50 (see above), we examined the effects of lower concentrations of inhibitor. ␣PC12 cells differentiated in NGF ϩ 1 M KN-62 displayed morphologies that were very similar to ␣PC12 cells differentiated in NGF alone (data not shown), whereas cells grown in NGF ϩ 5 M KN-62 displayed long neurites very similar to cells grown in NGF ϩ 10 M KN-62. KN-62 was added to cultures only once at the start of each experiment (1-2 hr after NGF addition), and its stability in cultures was not assessed; most experiments used 10 M KN-62. Phase-contrast microscopy also showed that cell-to-substrate adhesion of ␣PC12 cells decreased during differentiation in NGF ϩ KN-62. The number of growth cones per cell was not affected by KN-62 in either untransfected or ␣PC12 cells. Thus, KN-62 significantly altered the morphology and neurite extension of ␣CaMKII-overexpressing cells grown in NGF such that they appeared similar to untransfected PC12 cells during NGF-induced differentiation.
To further examine the apparent inhibition of neurite outgrowth in ␣CaMKII-overexpressing PC12 cells, cells were grown in NGF for 2 d and then time-lapse micrographs were taken at 3 hr intervals. Figure 5 shows that growth cones routinely form, grow in size, and then retract in Ͻ3 hr without extending neurites (growth cones marked with black arrowheads). Growth cones also appear to retract and reappear at the same location on a cell (growth cones marked with black and white arrowheads). In contrast, neurites of untransfected PC12 cells grown in NGF extended long distances from the cell body (Fig. 4 B) . These neurites do not retract during the course of 1 cell cycle (Waymire et al., 1978) . These results indicate that the activity of ␣CaMKII in overexpressing cells inhibits neurite elongation but not growth cone formation.
DISCUSSION
One goal of these studies was to develop a cell model that displays certain phenotypes of CNS neurons, such as the expression of high levels of the ␣CaMKII. This goal was achieved using PC12 cells transfected with ␣CaMKII cDNA under control of the strong CMV promoter. Comparison of many G418-resistant PC12 clones expressing high versus low or undetectable levels of ␣CaMKII showed that the properties described above were positively correlated with ␣CaMKII overexpression. ␣CaMKII overexpression resulted in increased cell-to-substrate adhesion (i.e., larger and flatter cells), decreased cell-to-cell adhesion, and growth saturation at lower cell densities. Furthermore, ␣CaMKII overexpression inhibited neurite outgrowth during NGF-induced differentiation.
A correlation between ␣CaMKII overexpression and cell morphology has been reported in neuroblastoma (NB2a) and NG-108 cells (Goshima et al., 1993) or PC12 cells (Tashima et al., 1996) using experimental strategies similar to ours. The major differences between our study and the latter studies are the cell models and differentiation protocols. We observed that transfected NB2a and NG-108 cells did not express very high levels of ␣CaMKII compared with hippocampal or cortical tissues, which we believe is important to assess the enzymatic and structural roles of ␣CaMKII in neuronal functions. In addition, we used NGF as a morphogen, whereas the other studies used membrane-permeable cyclic nucleotide analogs (i.e., dibutyryl-cAMP or 8-bromo-cAMP), and cAMP analogs may cause a short-term induction of CRE-containing promoters (e.g., c-fos) followed by a downregulation or refractory period (Gius et al., 1990; Foulkes et al., 1991; Marksitzer et al., 1995) (Massé and Kelly, unpublished observations) . It is also possible that long-term activation of cAMP pathways may enhance other phosphorylation pathways, including those mediated by CaMKII. For example, the phosphorylation of inhibitor-1 by PKA will increase the inhibition of type-1 protein phosphatase that dephosphorylates many proteins phosphorylated by CaMKII (Shields et al., 1985) . In our studies, the differentiation of ␣PC12 cells with dibutyryl-or 8-bromocAMP decreased the levels of ␣CaMKII mRNA and protein. In contrast, growth of overexpressing PC12 cells in NGF for 1-5 d did not significantly change their cellular content of ␣CaMKII or its in vitro catalytic activity assayed with cell extracts.
In agreement with Goshima et al. (1993) , we found that ␣CaMKII overexpression enhances cell-to-substrate adhesion. However, our studies with PC12 cells show that increased adhesion does not stimulate neurite outgrowth, suggesting that high levels of ␣CaMKII activity inhibit other mechanisms involved in growth cone motility. With regard to the properties of NGFversus cAMP-induced differentiation, we observed that the retarded neurite outgrowth of ␣PC12 cells was reversed by the CaMKII inhibitor KN-62; this reversal was not observed by Tashima et al. (1996) . Because the inhibition of neurite extension in ␣PC12 cells was reversed with KN-62, it seems unlikely that our results were attributable to selecting G418-resistant PC12 clones that were simply defective in extending neurites.
Although ␣CaMKII overexpression altered the growth and neurite extension properties of PC12 cells, it did not compromise their ability to respond to NGF; growth cones formed rapidly after adding NGF, and the relative abundance of NGF receptors in PC12 cells as determined immunohistochemically changed very little in ␣CaMKII-overexpressing cells (data not shown). Neurite elongation appeared to be inhibited by CaMKII catalytic activity. This inhibition seemed to be attributable to growth cone instability of ␣PC12 cells grown in NGF, because growth cones emerged transiently and repetitively without forming neurites (Massé and Kelly, unpublished observations) . ␣CaMKII overexpression did not dramatically change the percentage of Ca 2ϩ -independent CaMKII activity in cells relative to total Ca 2ϩ /CaM-stimulated CaM-kinase activity. Although ␣PC12 cells contained three-to fourfold higher absolute levels of Ca 2ϩ -independent CaMKII activity compared with untransfected cells, we believe this activity is unlikely to contribute to the distinct phenotype of ␣PC12 cells. This is based on the fact that the CaMKII inhibitor KN-62 is competitive with Ca 2ϩ /CaM and does not inhibit Ca 2ϩ -independent CaMKII activity (Tokumitsu et al., 1990) . Our results show that the apparent inhibition of Ca 2ϩ /CaM-dependent CaMKII activity with KN-62 resulted in growth cone stabilization and neurite extension and suggest that ␣CaMKII activity in ␣PC12 cells inhibits neurite outgrowth by disrupting one or more steps in the mechanism of neurite elongation, possibly through increased phosphorylation of specific protein substrates (Tokui et al., 1990; Lapadula et al., 1991) . Mechanisms that regulate neurite extension and growth cone motility most likely require a dynamic balance between Ca 2ϩ /CaM-dependent protein kinase and phosphatase activities. Recent observations show that the Ca 2ϩ /CaMdependent protein phosphatase calcineurin functions in neurite outgrowth and directed filopodia motility in dorsal root ganglion neurons (Chang et al., 1995) .
Results published recently suggest that KN-62 may have additional actions besides inhibiting CaM kinases. For example, KN-62 appears to inhibit Ca 2ϩ influx in adrenal chromaffin cells (Maurer et al., 1996) ; however, KN-62 had no observable effect on cell morphology. Additional data suggest that KN-62 blocks voltage-gated Ca 2ϩ channels in adrenal chromaffin cells (Marley and Thomson, 1996) , whereas it does not affect Ca 2ϩ currents in hippocampal CA1 neurons (Wyllie and Nicoll, 1994) . It is also important to note that CaM-kinase activity can upregulate Ca 2ϩ channel activity (Wang and Best, 1992; Kitamura et al., 1993) , which suggests that cells treated with KN-62 may indirectly downregulate Ca 2ϩ channel influx attributable to KN-62's inhibition of CaM-kinase.
␣CaMKII-overexpressing cells displayed altered growth properties, including decreased replication rates, enhanced contact inhibition, and greatly enhanced survival after reaching confluency, compared with untransfected PC12 cells. This result suggests that ␣CaMKII may enhance cell-to-cell signaling that regulates cell replication as well as participates in maintaining metabolic homeostasis during quiescence. Because the expression of ␣CaMKII in postmitotic neurons in vivo remains high in the adult brain (Rostas et al., 1983; Burgin et al., 1990) , our discovery that ␣CaMKII overexpression greatly enhances cell survival at confluency suggests that CaMKII contributes to cellular homeostasis and longevity of neurons in the brains of adult and aging humans. The mechanisms underlying such roles for CaMKII in neuronal function probably involve the regulation of gene expression (Sheng et al., 1990; Lerea and McNamara, 1993) . However, it is tempting to propose that certain features of the ␣CaMKII-overexpression phenotype is attributable to a direct regulation of cytoskeletal functions by CaMKII (Iwig et al., 1995) (Massé and Kelly, unpublished observations) .
